These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 14604680

  • 1. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors.
    Jiang DJ, Hu GY, Jiang JL, Xiang HL, Deng HW, Li YJ.
    Bioorg Med Chem; 2003 Nov 17; 11(23):5171-7. PubMed ID: 14604680
    [Abstract] [Full Text] [Related]

  • 2. Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor.
    Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW, Li YJ.
    Acta Pharmacol Sin; 2004 Jul 17; 25(7):893-901. PubMed ID: 15210062
    [Abstract] [Full Text] [Related]

  • 3. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway.
    Tan B, Jiang DJ, Huang H, Jia SJ, Jiang JL, Hu CP, Li YJ.
    Vascul Pharmacol; 2007 May 17; 46(5):338-45. PubMed ID: 17293168
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level.
    Tang WJ, Hu CP, Chen MF, Deng PY, Li YJ.
    Can J Physiol Pharmacol; 2006 Feb 17; 84(2):163-71. PubMed ID: 16900942
    [Abstract] [Full Text] [Related]

  • 5. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
    Yang TL, Chen MF, Luo BL, Xie QY, Jiang JL, Li YJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May 17; 371(5):401-7. PubMed ID: 15915325
    [Abstract] [Full Text] [Related]

  • 6. [Protective effect of losartan on injury induced by ox-LDL in endothelial cells and the relationship with asymmetric dimethylarginine].
    Xie QY, Sun ZL, Chen MF, Yang TL.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb 17; 31(1):66-9. PubMed ID: 16562679
    [Abstract] [Full Text] [Related]

  • 7. Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level.
    Jiang DJ, Jiang JL, Tan GS, Huang ZZ, Deng HW, Li YJ.
    Planta Med; 2003 Dec 17; 69(12):1150-2. PubMed ID: 14750034
    [Abstract] [Full Text] [Related]

  • 8. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL, Zhang XH, Li NS, Rang WQ, Feng-Ye, Hu CP, Li YJ, Deng HW.
    Cardiovasc Drugs Ther; 2006 Aug 17; 20(4):281-94. PubMed ID: 16897158
    [Abstract] [Full Text] [Related]

  • 9. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine.
    Jiang DJ, Jiang JL, Tan GS, Du YH, Xu KP, Li YJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun 17; 367(6):600-6. PubMed ID: 12750878
    [Abstract] [Full Text] [Related]

  • 10. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.
    Deng S, Deng PY, Jiang JL, Ye F, Yu J, Yang TL, Deng HD, Li YJ.
    Acta Pharmacol Sin; 2004 Dec 17; 25(12):1633-9. PubMed ID: 15569408
    [Abstract] [Full Text] [Related]

  • 11. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes.
    Böger RH, Bode-Böger SM, Tsao PS, Lin PS, Chan JR, Cooke JP.
    J Am Coll Cardiol; 2000 Dec 17; 36(7):2287-95. PubMed ID: 11127475
    [Abstract] [Full Text] [Related]

  • 12. Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
    Jiang DJ, Jiang JL, Zhu HQ, Tan GS, Liu SQ, Xu KP, Li YJ.
    J Ethnopharmacol; 2004 Aug 17; 93(2-3):295-306. PubMed ID: 15234768
    [Abstract] [Full Text] [Related]

  • 13. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
    Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P.
    Circ Res; 2002 Apr 19; 90(7):764-9. PubMed ID: 11964368
    [Abstract] [Full Text] [Related]

  • 14. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov 19; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 15. Role of asymmetric dimethylarginine in inflammatory reactions by angiotensin II.
    Chen MF, Xie XM, Yang TL, Wang YJ, Zhang XH, Luo BL, Li YJ.
    J Vasc Res; 2007 Nov 19; 44(5):391-402. PubMed ID: 17551258
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.
    Tanaka M, Sydow K, Gunawan F, Jacobi J, Tsao PS, Robbins RC, Cooke JP.
    Circulation; 2005 Sep 13; 112(11):1549-56. PubMed ID: 16144995
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M, Liu L, Guo Z, Xiong Y.
    Eur J Pharmacol; 2008 Apr 14; 584(1):49-56. PubMed ID: 18342305
    [Abstract] [Full Text] [Related]

  • 20. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.